Sign In
Buy ZYXI
$0.125
+0 (+0%)
At Close: Mar 20, 2026
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award
09:15am, Tuesday, 02'nd Apr 2024
ENGLEWOOD, Colo., April 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex (ZYXI) CEO on the Medical Device Industry
04:38pm, Friday, 01'st Mar 2024
Zynex (ZYXI) is a medical device manufacturer with products for pain management, injury rehab, and medical monitoring. CEO Thomas Sandgaard joins Oliver Renick to discuss the company's earnings.
Zynex, Inc. (ZYXI) Q4 2023 Earnings Call Transcript
08:12pm, Thursday, 29'th Feb 2024
Zynex, Inc. (ZYXI) Q4 2023 Earnings Call Transcript
Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates
06:21pm, Thursday, 29'th Feb 2024
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.20 per share a year ago.
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results
04:01pm, Thursday, 29'th Feb 2024
FY 2023 Revenue Increased 17% to $184.3 Million Company Announces Additional $20 Million Stock Repurchase Plan ENGLEWOOD, Colo. , Feb. 29, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovativ
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
09:15am, Thursday, 22'nd Feb 2024
ENGLEWOOD, Colo. , Feb. 22, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex Introduces New Products
09:15am, Tuesday, 20'th Feb 2024
ENGLEWOOD, Colo. , Feb. 20, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex Receives FDA Clearance for its Next Generation NMES Device
09:15am, Tuesday, 06'th Feb 2024
ENGLEWOOD, Colo. , Feb. 6, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex Recognized in Top 25 Medical Device Companies for 2024
09:15am, Friday, 02'nd Feb 2024
ENGLEWOOD, Colo. , Feb. 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
3 Unloved Growth Stocks Poised for a Major Turnaround
01:27pm, Sunday, 28'th Jan 2024
The stock market recovery over the past couple of years has been anything but evenly-distributed. A handful of high-flying tech stocks dubbed the “Magnificent Seven” have largely powered the rebou
Zynex to Participate at the Needham Annual Growth Conference
09:15am, Monday, 08'th Jan 2024
ENGLEWOOD, Colo. , Jan. 8, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m
Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024"
09:15am, Wednesday, 15'th Nov 2023
ENGLEWOOD, Colo. , Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex Inc. (ZYXI) Q3 Earnings Match Estimates
06:49pm, Thursday, 26'th Oct 2023
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.13 per share a year ago.
Zynex, Inc Sets Third Quarter 2023 Earnings Call
09:15am, Thursday, 12'th Oct 2023
ENGLEWOOD, Colo. , Oct. 12, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
3 Micro-Cap Stocks to Sell While You Still Can
09:00am, Friday, 06'th Oct 2023
The Federal Reserve signaling interest rates could stay elevated for the long term coupled with relentless political infighting in Washington has brought another jolt of volatility to equities. This h
